Related Experiment Video
Updated: Aug 3, 2026

08:09
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
9.6K
Residue-Level Characterization of Antibody Binding Epitopes Using Carbene Chemical Footprinting
Jason M Hogan1, Peter S Lee1, Susan C Wong1
1Discovery Biotherapeutics, Bristol Myers Squibb, 700 Bay Road, Redwood City, California 94063, United States.
Analytical Chemistry
|February 15, 2023
Summary
Carbene chemical footprinting precisely maps antibody binding sites, accelerating therapeutic antibody discovery. This mass spectrometry technique identifies single-residue epitopes, enhancing drug development and understanding.
Area of Science:
- Biochemistry
- Immunology
- Drug Discovery
Background:
- Antibody binding epitope characterization is crucial for therapeutic drug discovery, influencing antibody pharmacology and pharmacokinetics.
- Understanding the precise binding site is essential for selecting and developing effective antibody-based therapeutics.
Purpose of the Study:
- To introduce a novel carbene chemical footprinting method coupled with mass spectrometry for high-resolution antibody epitope mapping.
- To demonstrate the application of this technique for characterizing epitopes of MICA and CTLA-4 antibodies.
Main Methods:
- Utilized photoactivated diazirine reagents for carbene chemical footprinting to label antibody binding interfaces.
- Employed mass spectrometry for identification of labeled residues at a single-residue level.
- Validated findings using X-ray crystallography and yeast surface display epitope mapping.
Main Results:
- Successfully mapped antibody binding epitopes at single-residue resolution.
- Provided complementary labeling information using two different diazirine reagents for structural refinement.
- Enabled structural understanding of competitive binding interactions and antibody selection.
Conclusions:
- Carbene footprinting offers a rapid, high-resolution method for epitope characterization in antibody discovery.
- This technique accelerates the drug discovery process by providing critical mechanistic insights into antibody function.
- Facilitates informed antibody selection and development for therapeutic applications.

